Clinical trial
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's…
NCT00087425 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00087425 |
|---|---|
| Title | Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia |
| Official title | A Phase II Trial Of Bryostatin-1 In Combination With Rituximab In Rituximab-Refractory Indolent B-cell Non Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | rituximab, bryostatin 1 |
| Enrollment | 48 |
| Start date | Jul 1, 2004 |
| Primary completion | Oct 1, 2007 |
| First posted | Jul 12, 2004 |
| Last update posted | Apr 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: